Cryptococcosis in AIDS patients: observations concerning CNS involvement

Area of Science:

• Infectious Diseases
• Mycology
• Immunology

Background:

• Cryptococcosis is a serious opportunistic infection in patients with acquired immunodeficiency syndrome (AIDS).
• The clinical presentation of cryptococcosis in AIDS patients can range from primary respiratory infection to disseminated disease involving the central nervous system.

Purpose of the Study:

• To review the clinical course and treatment response of seven patients with cryptococcosis and AIDS.
• To evaluate the effectiveness and adverse effects of antifungal therapy in this patient population.

Main Methods:

• Retrospective review of clinical data from seven patients diagnosed with cryptococcosis and AIDS.
• Analysis of diagnostic methods, clinical manifestations, and treatment regimens, including amphotericin B and flucytosine.

Main Results:

• Six patients presented with secondary cryptococcosis (disseminated disease), while one was in the primary stage (respiratory tract).
• Central nervous system involvement was common, presenting with headache, fever, and nausea, though meningism and mental changes were rare.
• Antifungal therapy with amphotericin B and flucytosine demonstrated high efficacy, with negative fungal cultures in most cases.
• Adverse drug reactions, including anemia, hepatosis, and fever, were frequently observed.

Conclusions:

• Antifungal treatment with amphotericin B and flucytosine is effective for cryptococcosis in AIDS patients.
• Early diagnosis, particularly in the primary stage, may lead to improved prognosis.
• Close monitoring for adverse drug reactions is essential during treatment.